We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Phase 2 Clinical Trial of APN01 for Treatment of COVID-19 Inititated

News   Apr 02, 2020 | Original story from APEIRON Biologics

 
Phase 2 Clinical Trial of APN01 for Treatment of COVID-19 Inititated

Credit: Pixabay

 
 
Advertisement
 

RELATED ARTICLES

Proteins in the Blood of COVID-19 Patients Could Help Predict How Ill They Will Become

News

Researchers have found 27 potential biomarkers that are present in different levels in patients with COVID-19, depending on the severity of their symptoms. The markers could help doctors to predict how ill a patient will become and provide scientists with new targets for drug development.

READ MORE

Trial Investigates Unique Formulation of Ibuprofen as Treatment for COVID-19 Respiratory Complication

News

A trial is investigating a unique formulation of ibuprofen as a treatment for severe acute respiratory distress syndrome (ARDS), a complication of COVID-19.

READ MORE

Scouring Microbial Metabolic Pathways in the Pursuit of New Therapeutics

News

In a new study, researchers at the Centre for Genomic Regulation (CRG), in Barcelona, describe a new method for determining active metabolic pathways in microbes using cutting-edge techniques from genomics and proteomics.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE